Newgenivf Group Ltd balance sheet

At the end of fiscal 2025, Newgenivf Group Ltd had total assets of $32.7m, total liabilities of $6.7m and shareholders' equity of $26.6m. It held $758,621 in cash against $4.4m of debt: net debt of $3.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Newgenivf Group Ltd: balance sheet, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	0	0	0	0	1
Receivables	—	0	0	0	0
Inventory	—	0	0	0	0
Total current assets	—	2	2	3	7
Total assets	—	3	4	4	33
Accounts payable	—	0	0	1	1
Deferred revenue (current)	—	1	0	0	0
Total current liabilities	—	3	1	3	2
Long-term debt	—	—	—	2	4
Total debt	0	0	0	2	4
Total liabilities	—	3	1	5	7
Shareholders' equity	−1	1	4	−1	27
Non-controlling interests and other (assets − liabilities − equity)	—	−0	−0	−0	—
Net debt (negative = net cash)	−0	−0	−0	2	4
Shares outstanding	—	—	—	—	4m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BMGL vs NIVF CCM vs NIVF NIVF vs SNDA

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Newgenivf Group Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Newgenivf Group Ltd.